Sage Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-43,027
Closed -$1.76M 113
2021
Q2
$1.76M Buy
43,027
+4,082
+10% +$159K 0.72% 43
2021
Q1
$1.41M Buy
38,945
+315
+0.8% +$11.2K 0.63% 44
2020
Q4
$1.35M Sell
38,630
-1,828
-5% -$67.1K 0.66% 42
2020
Q3
$1.41M Buy
40,458
+237
+0.6% +$8.31K 0.86% 35
2020
Q2
$1.25M Sell
40,221
-140
-0.3% -$4.76K 0.8% 36
2020
Q1
$1.25M Buy
40,361
+3,274
+9% +$112K 1.02% 31
2019
Q4
$1.38M Buy
37,087
+900
+2% +$32.1K 0.88% 38
2019
Q3
$1.23M Buy
36,187
+213
+0.6% +$7.75K 0.93% 37
2019
Q2
$1.47M Sell
35,974
-412
-1% -$16.4K 1.02% 34
2019
Q1
$1.47M Sell
36,386
-24,980
-41% -$1M 0.94% 33
2018
Q4
$2.54M Sell
61,366
-16,251
-21% -$675K 1.92% 19
2018
Q3
$3.25M Buy
77,617
+524
+0.7% +$20.2K 2.03% 19
2018
Q2
$2.65M Buy
77,093
+325
+0.4% +$11.1K 1.86% 20
2018
Q1
$2.58M Buy
76,768
+824
+1% +$28.3K 1.83% 21
2017
Q4
$2.61M Buy
75,944
+433
+0.6% +$14.8K 1.69% 20
2017
Q3
$2.56M Buy
75,511
+2,511
+3% +$80.7K 1.8% 20
2017
Q2
$2.33M Buy
+73,000
New +$2.3M 1.71% 22

Other funds holding PFE

Sage Capital Advisors's PFE Position: Q3 2021 in Review

Sage Capital Advisors sold out of Pfizer (PFE) in Q3 2021, closing a stake of 43,027 shares — an estimated $1.76M sold.

Sage Capital Advisors first reported a position in PFE in Q2 2017 and held it in 17 quarters. The position peaked at $3.25M in Q3 2018. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Sage Capital Advisors reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
  • Sage Capital Advisors sold 43,027 Pfizer shares in Q3 2021, an estimated $1.76M.
  • Sage Capital Advisors first reported a position in Pfizer in Q2 2017 and held it in 17 quarters.
  • Sage Capital Advisors's Pfizer position peaked at $3.25M in Q3 2018.
  • 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Sage Capital Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.